{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:28:03Z","timestamp":1773836883328,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.medcli.2011.10.011","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T21:30:27Z","timestamp":1323984627000},"page":"25-32","source":"Crossref","is-referenced-by-count":11,"title":["Talidomida: 50 a\u00f1os despu\u00e9s"],"prefix":"10.1016","volume":"139","author":[{"given":"Maria Luisa","family":"Mart\u00ednez-Fr\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2011.10.011_bib0005","first-page":"2555","article-title":"Kindliche Mi\u03b2bildungen nach Medikament-Einnahme w\u00e4hrend der Gravidit\u00e4t?","volume":"86","author":"Lenz","year":"1961","journal-title":"Dtsch Med Wschr"},{"key":"10.1016\/j.medcli.2011.10.011_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(62)92665-X","article-title":"Thalidomide and congenital abnormalities [letter]","volume":"1","author":"Lenz","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2011.10.011_bib0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/tera.1420460505","article-title":"A personal perspective on the thalidomide tragedy","volume":"46","author":"Lenz","year":"1992","journal-title":"Teratology"},{"key":"10.1016\/j.medcli.2011.10.011_bib0020","unstructured":"Mart\u00ednez-Fr\u00edas ML. \u00bfQu\u00e9 medicamentos se pueden utilizar durante el embarazo? Propositus Hoja Informativa del ECEMC. Disponible en: http:\/\/www.ciberer.es\/documentos\/11-Propositus%2026.pdf"},{"key":"10.1016\/j.medcli.2011.10.011_bib0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2011.10.011_bib0030","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1067\/mjd.2001.113720","article-title":"Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid","volume":"45","author":"Nau","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tera.1420380303","article-title":"A short history of thalidomide embryopathy","volume":"38","author":"Lenz","year":"1988","journal-title":"Teratology"},{"key":"10.1016\/j.medcli.2011.10.011_bib0040","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/bmj.2.5217.1954","article-title":"Is thalidomide to blame?","volume":"2","author":"Florence","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.medcli.2011.10.011_bib0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/tera.1420380305","article-title":"Thalidomide update: regulatory aspects","volume":"38","author":"Kelsey","year":"1988","journal-title":"Teratology"},{"key":"10.1016\/j.medcli.2011.10.011_bib0050","first-page":"607","article-title":"Consideraciones sobre dos casos de focomelia. Embriopat\u00eda por talidomida","volume":"18","author":"Carbonell Juanico","year":"1962","journal-title":"Rev Esp Pediatr"},{"key":"10.1016\/j.medcli.2011.10.011_bib0055","first-page":"225","article-title":"Clinical observations on the thalidomide syndrome","volume":"70","author":"Newmann","year":"1977","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.medcli.2011.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/bies.200900103","article-title":"Thalidomide-induced limb defects: resolving a 50-year-old puzzle","volume":"31","author":"Vargesson","year":"2009","journal-title":"Bioessays"},{"key":"10.1016\/j.medcli.2011.10.011_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1517\/14740338.2011.527331","article-title":"Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective","volume":"10","author":"Bwire","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.medcli.2011.10.011_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.medcli.2011.10.011_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(63)92402-4","article-title":"Thalidomide in Japan","volume":"1","author":"Kajii","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2011.10.011_bib0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.1.5848.269","article-title":"Defect and disabilities of thalidomide children","volume":"1","author":"Smithells","year":"1973","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2011.10.011_bib0085","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jmg.29.10.716","article-title":"Recognition of thalidomide defects","volume":"29","author":"Smithells","year":"1992","journal-title":"J Med Genet"},{"key":"10.1016\/j.medcli.2011.10.011_bib0090","first-page":"11","article-title":"La experiencia de la Talidomida","volume":"4","author":"Lenz","year":"1993","journal-title":"Bol ECEMC Rev Dismor Epidemiol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y","article-title":"Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses","volume":"60","author":"Miller","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.medcli.2011.10.011_bib0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/tera.1420320118","article-title":"Teratogen update: clinical aspects of thalidomide embryopathy--a continuing preoccupation","volume":"32","author":"Newman","year":"1985","journal-title":"Teratology"},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2011.10.011_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00007611-197102001-00007","article-title":"How can the teratogenic action of a factor be established in man?","volume":"64","author":"Lenz","year":"1971","journal-title":"So Med J"},{"key":"10.1016\/j.medcli.2011.10.011_bib0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajmg.10781","article-title":"Teratogen-induced limb defects","volume":"112","author":"Holmes","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.medcli.2011.10.011_bib0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.semerg.2010.09.003","article-title":"Tratamiento farmacol\u00f3gico de la mujer embarazada: f\u00e1rmacos contraindicados durante la gestaci\u00f3n","volume":"36","author":"Rodr\u00edguez-Pinilla","year":"2010","journal-title":"Semergen"},{"key":"10.1016\/j.medcli.2011.10.011_bib0120","unstructured":"ICBDMS. Disponible en: http:\/\/www.icbdsr.org\/"},{"key":"10.1016\/j.medcli.2011.10.011_bib0125","unstructured":"EUROCAT. Disponible en: http:\/\/www.eurocat-network.eu\/"},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2011.10.011_bib0130","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/bdra.20775","article-title":"Paper 6: EUROCAT member registries: organization and activities","volume":"91","author":"Greenlees","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/tera.10069","article-title":"Classification of drugs for teratogenic risk: an anachronistic way of counseling","volume":"66","author":"Merlob","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.medcli.2011.10.011_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdra.20748","article-title":"Human teratogens: update 2010","volume":"91","author":"Holmes","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1741-4520.2010.00308.x","article-title":"Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services","volume":"51","author":"Schaefer","year":"2011","journal-title":"Congeni Anom (Kyoto)"},{"key":"10.1016\/j.medcli.2011.10.011_bib0150","unstructured":"OTIS. Disponible en: http:\/\/www.otispregnancy.org\/"},{"key":"10.1016\/j.medcli.2011.10.011_bib0155","unstructured":"ENTIS. Disponible en: http:\/\/www.entis-org.com\/"},{"key":"10.1016\/j.medcli.2011.10.011_bib0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/chir.530070109","article-title":"Stereospecific determination, chiral inversion in vitro, and pharmacokinetics in humans of the enantiomers of thalidomide","volume":"7","author":"Eriksson","year":"1995","journal-title":"Chirality"},{"key":"10.1016\/j.medcli.2011.10.011_bib0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.medcli.2011.10.011_bib0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1979.04010050060027","article-title":"Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis","volume":"115","author":"Mascar\u00f3","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/bmj.298.6671.432","article-title":"Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody","volume":"298","author":"Youle","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2011.10.011_bib0180","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.medcli.2011.10.011_bib0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10428190290006143","article-title":"Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia","volume":"43","author":"Johnston","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.medcli.2011.10.011_bib0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1157\/13120342","article-title":"Nuevas estrategias terap\u00e9uticas en el tratamiento del mieloma m\u00faltiple. An\u00e1lisis de su eficacia y coste-efectividad","volume":"130","author":"Garc\u00eda Quetglas","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2011.10.011_bib0195","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3748\/wjg.v17.i10.1286","article-title":"Treatment of pediatric refractory Crohn's disease with thalidomide","volume":"17","author":"Zheng","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/RCT.0b013e31820ccf51","article-title":"Perfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experience","volume":"35","author":"Petralia","year":"2011","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.medcli.2011.10.011_bib0205","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/leu.2011.54","article-title":"Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma","volume":"25","author":"Kapoor","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2011.10.011_bib0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eplepsyres.2010.10.003","article-title":"Thalidomide for treatment of refractory epilepsy","volume":"92","author":"Palencia","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.medcli.2011.10.011_bib0215","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0006-2952(99)00388-3","article-title":"Mechanism of action in thalidomide teratogenesis","volume":"59","author":"Stephens","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0220","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-010-0619-9","article-title":"Teratogenic effects of thalidomide: molecular mechanisms","volume":"68","author":"Ito","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.medcli.2011.10.011_bib0225","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0901505106","article-title":"Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation","volume":"106","author":"Therapontos","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.medcli.2011.10.011_bib0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0892-0362(03)00010-2","article-title":"Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established","volume":"25","author":"Kalter","year":"2003","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.medcli.2011.10.011_bib0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.reprotox.2009.09.003","article-title":"Fetal malformations and early embryonic gene expression response in cynomolgus monkeys maternally exposed to thalidomide","volume":"29","author":"Ema","year":"2010","journal-title":"Reprod Toxicol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775311010359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775311010359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T14:28:04Z","timestamp":1543328884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775311010359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0025775311010359"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2011.10.011","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}